Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery

Completed · Not applicable

Conditions studied: Blepharitis, Dry Eye Syndrome

In brief

The purpose of this pilot feasibility study is to assess whether treating meibomian gland dysfunction (MGD) prior to cataract surgery helps promote meibomian gland function, visual quality and ocular comfort after cataract surgery.

Key facts

Study ID
NCT01808560
Run by
TearScience, Inc.
People needed
34
Starts
2013-03-01
Expected to finish
2015-01-01
Last updated by the study team
2018-09-04

Who can join

Age: 55 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.